199 related articles for article (PubMed ID: 33978812)
1. Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities.
Würnschimmel C; Wenzel M; Collà Ruvolo C; Nocera L; Tian Z; Saad F; Briganti A; Shariat SF; Mandel P; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
World J Urol; 2021 Oct; 39(10):3781-3787. PubMed ID: 33978812
[TBL] [Abstract][Full Text] [Related]
2. Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients.
Hoeh B; Hohenhorst JL; Flammia R; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
Int Urol Nephrol; 2022 Jan; 54(1):81-87. PubMed ID: 34783982
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
[TBL] [Abstract][Full Text] [Related]
4. Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients.
Hoeh B; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
Prostate; 2022 Jan; 82(1):120-131. PubMed ID: 34662443
[TBL] [Abstract][Full Text] [Related]
5. Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.
Bandini M; Marchioni M; Preisser F; Zaffuto E; Tian Z; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
World J Urol; 2018 Sep; 36(9):1399-1407. PubMed ID: 29717358
[TBL] [Abstract][Full Text] [Related]
6. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
Int Urol Nephrol; 2022 Jul; 54(7):1521-1527. PubMed ID: 35508792
[TBL] [Abstract][Full Text] [Related]
7. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.
Wenzel M; Deuker M; Stolzenbach F; Nocera L; Collà Ruvolo C; Tian Z; Shariat SF; Saad F; Briganti A; Kluth LA; Chun FKH; Karakiewicz PI
Urol Oncol; 2021 Jun; 39(6):369.e9-369.e17. PubMed ID: 33309509
[TBL] [Abstract][Full Text] [Related]
8. PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions.
Deuker M; Stolzenbach LF; Pecoraro A; Rosiello G; Luzzago S; Tian Z; Saad F; Chun FK; Karakiewicz PI
World J Urol; 2021 Mar; 39(3):787-796. PubMed ID: 32458094
[TBL] [Abstract][Full Text] [Related]
9. Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups.
Hoeh B; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Tilki D; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
Prostate; 2022 May; 82(6):676-686. PubMed ID: 35188981
[TBL] [Abstract][Full Text] [Related]
10. External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients.
Würnschimmel C; Wenzel M; Chierigo F; Flammia RS; Tian Z; Saad F; Briganti A; Shariat SF; Suardi N; Terrone C; Gallucci M; Chun FK; Tilki D; Graefen M; Karakiewicz PI
Int J Urol; 2022 Jan; 29(1):17-24. PubMed ID: 34553428
[TBL] [Abstract][Full Text] [Related]
11. Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy.
Wenzel M; Würnschimmel C; Chierigo F; Tian Z; Shariat SF; Terrone C; Saad F; Tilki D; Graefen M; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
Prostate; 2021 Aug; 81(11):728-735. PubMed ID: 34010465
[TBL] [Abstract][Full Text] [Related]
12. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.
Bernard B; Muralidhar V; Chen YH; Sridhar SS; Mitchell EP; Pettaway CA; Carducci MA; Nguyen PL; Sweeney CJ
Cancer; 2017 May; 123(9):1536-1544. PubMed ID: 28055108
[TBL] [Abstract][Full Text] [Related]
13. Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer-Specific Mortality.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Soulières D; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2018 Oct; 16(5):376-384.e1. PubMed ID: 29954690
[TBL] [Abstract][Full Text] [Related]
14. The effect of race on stage at presentation and survival in upper tract urothelial carcinoma.
Collà Ruvolo C; Wenzel M; Nocera L; Würnschimmel C; Tian Z; Shariat SF; Saad F; Longo N; Imbimbo C; Briganti A; Mirone V; Karakiewicz PI
Urol Oncol; 2021 Nov; 39(11):788.e7-788.e13. PubMed ID: 34330651
[TBL] [Abstract][Full Text] [Related]
15. Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients.
Wenzel M; Collà Ruvolo C; Würnschimmel C; Nocera L; Tian Z; Saad F; Briganti A; Tilki D; Graefen M; Becker A; Roos F; Mandel P; Chun FKH; Karakiewicz PI
Prostate; 2022 Jan; 82(1):78-85. PubMed ID: 34633102
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer characteristics and cancer-specific mortality of Native American patients.
Deuker M; Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Tian Z; Saad F; Chun F; Karakiewicz PI
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):277-285. PubMed ID: 31695139
[TBL] [Abstract][Full Text] [Related]
17. African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043366
[TBL] [Abstract][Full Text] [Related]
18. Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups.
Würnschimmel C; Wenzel M; Collà Ruvolo C; Nocera L; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FK; Tilki D; Graefen M; Karakiewicz PI
Int J Urol; 2021 Aug; 28(8):862-869. PubMed ID: 33993551
[TBL] [Abstract][Full Text] [Related]
19. The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients.
Nocera L; Wenzel M; Collà Ruvolo C; Würnschimmel C; Tian Z; Gandaglia G; Fossati N; Chun FKH; Mirone V; Graefen M; Shariat SF; Saad F; Montorsi F; Briganti A; Karakiewicz PI
Urol Oncol; 2021 Nov; 39(11):785.e11-785.e17. PubMed ID: 33992522
[TBL] [Abstract][Full Text] [Related]
20. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
